Skip to main navigation
 

CytomX

 
  • About
    • Overview
    • Mission, Vision, Values
    • Executive Team
    • Board of Directors
    • Contact Us
  • Probody Therapeutics
    • Our Probody Approach
    • How Probody Therapeutics Work
    • A Versatile Platform
    • Scientific Publications & Presentations
  • Pipeline
    • Advancing a Pipeline
    • Lead Candidates
    • Clinical Trials
    • Access for HCPs/Patients
  • Partners
    • Opportunities
    • Current Partners
  • Investors & News
    • Corporate Profile
    • Press Releases
    • Events & Presentations
    • Scientific Publications
    • Corporate Governance
    • Stock Information
    • Financials & Filings
    • Analyst Coverage
    • Investor Resources
  • Culture & Careers
    • Overview
    • Xtraordinary Culture
    • Current Openings
    • Total Rewards Program
    • Corporate Amenities
Menu

Exciting things are happening here

SEC Filing Details

SEC Filing Details

Document Details

Form
DEF 14A
Filing Date
Apr 30, 2026
Document Date
Jun 17, 2026
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
CytomX Therapeutics, Inc.
Issuer
CytomX Therapeutics, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.DEF - INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE
EX-101.PRE - INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT
  • Corporate Profile
  • Press Releases
  • Events and Presentations
  • Scientific Publications
  • Corporate Governance
  • Stock Information
  • Financials & Filings
  • Analyst Coverage
  • Investor Resources
  • Investor Tools

  • Print Page
  • Email Page
  • RSS Feeds
  • Email Alerts
  • Contact IR

Contact Us

151 Oyster Point Blvd, Suite 400

South San Francisco, CA

94080-1913

IR@CytomX.com

Share

Linkedin Twitter © CYTOMX INC | CYTOMX, our corporate logo, IHZ, and PROBODY are trademarks of CytomX Therapeutics, Inc. All other brands and trademarks referenced herein are the property of their respective owners.
  • About
    • Overview
    • Mission, Vision, Values
    • Executive Team
    • Board of Directors
    • Contact Us
  • Probody Therapeutics
    • Our Probody Approach
    • How Probody Therapeutics Work
    • A Versatile Platform
    • Scientific Publications & Presentations
  • Pipeline
    • Advancing a Pipeline
    • Lead Candidates
    • Clinical Trials
    • Access for HCPs/Patients
  • Partners
    • Opportunities
    • Current Partners
  • Investors & News
    • Corporate Profile
    • Press Releases
    • Events & Presentations
    • Scientific Publications
    • Corporate Governance
    • Stock Information
    • Financials & Filings
    • Analyst Coverage
    • Investor Resources
  • Culture & Careers
    • Overview
    • Xtraordinary Culture
    • Current Openings
    • Total Rewards Program
    • Corporate Amenities
  • Home
    • Terms of Use
    • Privacy Policy